Nicorandil Zentiva (Nicorandil)

Nicorandil combines two mechanisms: it releases nitric oxide, which relaxes vascular smooth muscle, and it opens ATP‑sensitive potassium channels, leading to hyperpolarisation of the cell membrane. Together these actions cause dilation of coronary vessels and lower systemic vascular resistance, reducing both preload and afterload.

The appropriate dose of Nicorandil Zentiva is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and any concomitant medications. Dosage adjustments are made individually, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for nicorandil in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Nicorandil Zentiva, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nicorandil differs from traditional nitrates and beta‑blockers by simultaneously donating nitric oxide and activating potassium channels, offering both arterial and venous dilation. This dual action can provide symptom relief in patients who are intolerant to or have insufficient response to single‑mechanism agents.

Nicorandil Zentiva should be stored at room temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Nicorandil Zentiva is taken orally, usually with or without food as directed by a healthcare professional. The tablet should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

The most serious risks include severe hypotension, which can lead to dizziness, fainting or shock, and rare cases of gastrointestinal ulceration. Patients should seek immediate medical attention if they experience sudden drops in blood pressure, worsening chest pain, or signs of an allergic reaction.

Nicorandil is contraindicated in patients with known hypersensitivity to nicorandil or any of its excipients, and it should be avoided in individuals with severe hypotension, recent myocardial infarction, or uncontrolled heart failure unless specifically advised by a physician.